REPORT ID 137384

Global Somatostatin Receptor Type 4 Market Study 2016-2026, by Segment (CNTX-0290, NNC-26910,

Publish Date
Nov-19
Pages
52
Format
Electronic (PDF)

ummary

The global Somatostatin Receptor Type 4 market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. 
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
        CNTX-0290
        NNC-26910
        Veldoreotide
        Others
Demand Coverage (Market Size & Forecast,  Consumer Distribution):
        Alzheimer's Disease
        Cognitive Disorders
        Neuroendocrine Tumors
        Acromegally
        Others
Company Coverage (Sales data, Main Products & Services etc.):
        Crinetics Pharmaceuticals Inc
        Strongbridge Biopharma plc
Major Region Market
        North America
        Europe
        Asia-Pacific
        South America
        Middle East & Africa 
			   
Table of Content
1 Industry Overview
    1.1 Somatostatin Receptor Type 4 Industry
        1.1.1 Overview
        1.1.2 Products of Major Companies
    1.2 Market Segment
        1.2.1 Industry Chain
        1.2.2 Consumer Distribution
    1.3 Price & Cost Overview
2 Somatostatin Receptor Type 4 Market by Type
    2.1 By Type
       2.1.1 CNTX-0290
       2.1.2 NNC-26910
       2.1.3 Veldoreotide
       2.1.4 Others
    2.2 Market Size by Type
    2.3 Market Forecast by Type
3 Global Market Demand
    3.1 Segment Overview
        3.1.1 Alzheimer's Disease
        3.1.2 Cognitive Disorders
        3.1.3 Neuroendocrine Tumors
        3.1.4 Acromegally
        3.1.5 Others
    3.2 Market Size by Demand
    3.3 Market Forecast by Demand
4 Major Region Market
    4.1 Global Market Overview
        4.1.1 Market Size & Growth
        4.1.2 Market Forecast
    4.2 Major Region
        4.2.1 Market Size & Growth
        4.2.2 Market Forecast
5 Major Companies List
    5.1 Crinetics Pharmaceuticals Inc (Company Profile, Sales Data etc.)
    5.2 Strongbridge Biopharma plc (Company Profile, Sales Data etc.)
6 Conclusion